To do that, we provide a wide range of therapies and tools developed with insight from our experts and through our work within the industry. Whether you need the dependable performance of therapeutic apheresis, cell collection or cell processing procedures, our solutions deliver choice and adaptability.*
We deliver a combination of powerful, flexible platforms designed to treat multiple disease states with a dedication to maintaining patient safety and comfort. Delivering systems that perform multiple therapeutic protocols is only the beginning. Our customers enjoy ongoing support through training programs, education initiatives, and scientific and clinical literature.
Making the Transition
Change can be challenging, but transitioning from your COBE® Spectra Apheresis System to the Spectra Optia® Apheresis System is going to be a breeze.
Enabling Next-Generation Cancer Treatments
Cell-based immunotherapy is currently at the forefront in the development of new treatments for serious diseases. A quality apheresis collection is often the critical first step in the development of today's innovative immunotherapy treatments. Discover the Spectra Optia system and how it delivers high target cell collection with low non-target cell contamination, driving consistency and reproducibility.
Advancing Apheresis 2016 Award:
Solving Venous Access Challenges
Learn more about the award and apply now.
Terumo BCT's next-generation therapeutic apheresis and cell collection platform that allows operators to spend more time focusing on patient care.
A legacy therapeutic apheresis device that uses a versatile centrifugal technology platform to perform customizable procedures for a variety of patients.
*Product and protocol availability varies by country.
Products available in select markets.